Dozens of drugs, spanning everything from street stimulants to commonly prescribed hormones and even over-the-counter painkillers, have been linked to an increased risk of stroke. A 2021 clinical review assessed 81 drugs or drug classes and identified high-level associations for several widely used medications, including combined contraceptives, oral estrogen replacement therapy, erythropoietin, certain cancer drugs, and antipsychotics.1Stroke / American Heart Association. Drugs Associated With Ischemic Stroke: A Review for Clinicians Some of these raise the risk of a blood-clot-driven (ischemic) stroke, others make a bleeding (hemorrhagic) stroke more likely, and a handful can do both.
Illicit Stimulants
Cocaine and methamphetamine are among the most dangerous drugs for stroke risk. Both can cause dramatic spikes in blood pressure, damage blood vessel walls, trigger vasospasm (a sudden tightening of arteries that chokes off blood flow), and promote the formation of aneurysms that can rupture.2Brain Hemorrhages. The effect of cocaine and methamphetamine on saccular aneurysm formation and rupture: A literature review These effects are not limited to heavy, long-term users. A single binge can be enough to trigger a stroke, particularly in someone with an undiagnosed vascular weak spot like a small aneurysm.
The mechanisms at work overlap but are not identical. Cocaine blocks the reabsorption of norepinephrine and dopamine, which floods the body with fight-or-flight signals and constricts blood vessels. Methamphetamine does something similar but with a longer duration of action, meaning the cardiovascular stress lasts longer per dose. Both ischemic and hemorrhagic strokes have been reported with stimulant use, through pathways that include arrhythmias, blood vessel spasm, direct vascular toxicity, and acute hypertension severe enough to burst weakened arteries.3PubMed Central. A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse What makes stimulant-related strokes especially tragic is their tendency to strike younger people who would otherwise be at very low risk.
Hormonal Medications
Combined oral contraceptives and hormone replacement therapy (HRT) are among the prescription medications most consistently tied to stroke. A large Danish study found that women using oral contraceptives containing 30 to 40 micrograms of ethinyl estradiol faced roughly 1.5 to 2.2 times the risk of thrombotic stroke compared with non-users, depending on the type of progestin in the pill.4PubMed. Thrombotic stroke and myocardial infarction with hormonal contraception Lower-dose formulations (containing 20 micrograms of estrogen) carried somewhat less risk, and progestin-only pills did not show a statistically significant increase.
The risk appears to be highest in the first year of use, likely because introducing exogenous hormones shifts the blood’s clotting balance almost immediately.5PubMed. Oral Contraceptives, Hormone Replacement Therapy, and Stroke Risk After that initial period, risk persists but does not keep climbing. HRT prescribed for menopausal symptoms follows a similar pattern: early use is tied to a bump in stroke risk, particularly with oral (as opposed to transdermal) estrogen formulations.6International Journal of Epidemiology. Hormone replacement therapy, oral contraceptives and stroke risk For most younger women without additional risk factors like smoking, high blood pressure, or migraine with aura, the absolute risk from contraceptives remains low. But layering those risk factors together can shift the calculus substantially.
Over-the-Counter Cold and Diet Drugs
You might not think of the decongestant aisle as a stroke risk, but sympathomimetic amines found in some cold, cough, and weight-loss products have caused serious cerebrovascular events. Phenylpropanolamine (PPA) was once a common ingredient in diet pills and cold remedies before the FDA pulled it from the market due to its association with hemorrhagic stroke, particularly in young women. A case series documented intracerebral hemorrhage in 17 patients and subarachnoid hemorrhage in four, with cerebral angiography showing diffuse vasospasm in the majority.7PubMed. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs Pseudoephedrine, which is still available (though often behind the pharmacy counter), was implicated in a smaller number of cases in the same series.
These drugs work by constricting blood vessels to reduce nasal congestion, but that same vasoconstriction can spike blood pressure and, in susceptible people, trigger bleeding in the brain. The risk increases sharply with higher doses or when combined with other stimulants like caffeine. A related concern involves dietary supplements containing synephrine, a compound with similar pharmacology. One case report documented an ischemic stroke in an otherwise healthy young man using an ephedra-free supplement that combined synephrine and caffeine.8Mayo Clinic Proceedings. Ischemic Stroke Associated With Use of an Ephedra-Free Dietary Supplement Containing Synephrine Ephedra itself was already banned by the FDA for the same category of problems.
NSAIDs
Common painkillers like ibuprofen, naproxen, and prescription COX-2 inhibitors (celecoxib, formerly rofecoxib) have been linked to a modest increase in cardiovascular events, including stroke. The basic mechanism involves how these drugs affect the balance between two opposing chemical signals in your blood vessels: prostacyclin, which relaxes vessels and discourages clotting, and thromboxane, which does the opposite. COX-2-selective drugs suppress prostacyclin without touching thromboxane, tipping the balance toward clot formation.9PLOS ONE. Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project
The risk is not uniform across all NSAIDs. Individual drugs differ in their effects on blood pressure, kidney function, and the duration of platelet inhibition, all of which modify stroke risk in different directions.10PubMed Central. Risk of stroke associated with nonsteroidal anti-inflammatory drugs For someone taking an occasional ibuprofen for a headache, the added risk is negligible. The concern grows with chronic daily use, especially at higher doses and in people who already have high blood pressure or kidney disease. If you rely on NSAIDs for conditions like arthritis, this is worth discussing with a doctor, particularly if you carry other stroke risk factors.
Antipsychotics and Dementia
Antipsychotic medications carry a well-recognized stroke risk, especially in older adults with dementia. Regulatory agencies in multiple countries have issued warnings about prescribing these drugs to elderly dementia patients. A large population-based study found that current antipsychotic use in people with dementia was associated with about a 60% higher risk of stroke compared to non-use.11BMJ. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study A separate analysis of U.S. veterans found that the odds of stroke were roughly 1.8 times higher during periods of antipsychotic exposure, with older patients showing the greatest vulnerability.12PubMed. Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration
A meta-analysis looking specifically at patients with dementia found a marginally significant 16% increase in stroke risk across cohort studies, though when the analysis was split by drug type (older “typical” versus newer “atypical” antipsychotics), neither subgroup alone reached statistical significance, largely because of limited data.13PubMed Central. Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis The practical takeaway is that both generations of antipsychotics appear to carry risk in this population. The problem is that these medications are frequently prescribed off-label to manage agitation and behavioral symptoms in nursing home residents, making the risk-benefit conversation especially important.
Cancer Therapies
Several classes of cancer drugs raise stroke risk through different pathways. Drugs that block vascular endothelial growth factor (VEGF), such as bevacizumab and certain tyrosine kinase inhibitors, interfere with the body’s ability to maintain and repair blood vessels. A systematic review found that patients receiving VEGF inhibitors had about 1.8 times the risk of arterial blood clots, including stroke, compared with control groups.14PLoS ONE. Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer The absolute increase was relatively small (about a 1% difference), but for patients already on long treatment courses, even small per-cycle risks accumulate.
Newer immunotherapy drugs called immune checkpoint inhibitors have also been connected to a rare but serious complication: inflammation of blood vessels in the brain (cerebral vasculitis). This is part of the broader category of immune-related adverse events these drugs can trigger, where the unleashed immune system attacks the body’s own tissues.15PubMed. Immune checkpoint inhibitor-related CNS vasculitis – A systematic review and report of 6 cases Tamoxifen, used in breast cancer treatment, was also flagged in the 2021 clinical review as having a high level of association with ischemic stroke, likely because it affects the blood’s clotting tendency.
Antidepressants and Bleeding Risk
SSRIs (selective serotonin reuptake inhibitors) like fluoxetine, sertraline, and escitalopram affect platelets as well as mood. Platelets use serotonin as part of the clotting process, and SSRIs reduce the amount of serotonin available to them. This means SSRIs carry a mild antiplatelet effect, which in most contexts is harmless but can matter for people already at risk of brain bleeding. A study of patients who had already suffered an intracerebral hemorrhage found that SSRI use was associated with about a 31% higher risk of recurrent hemorrhage.16PubMed Central. Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage With Hemorrhage Recurrence and Depression Severity Among patients already at high risk for recurrence, the added risk was even steeper, nearly 80% higher compared with non-users.
This creates a genuine clinical dilemma. Depression after stroke is extremely common and independently worsens recovery. The same study found that SSRIs were also associated with better resolution of post-stroke depression. For most people who have never had a hemorrhagic stroke, the antiplatelet effect of SSRIs is not a meaningful worry. But for anyone with a history of brain bleeding, the choice of antidepressant deserves careful thought.
ADHD Stimulant Medications
Prescription stimulants like methylphenidate and amphetamine-based drugs used for ADHD raise heart rate and blood pressure, which has understandably prompted concern about stroke. The cardiovascular response to these medications has mainly been observed as modest increases in heart rate and blood pressure, while serious events like stroke remain rare.17PubMed Central. Adult ADHD Medications and Their Cardiovascular Implications There is more concern about adults than children, partly because adults are more likely to have preexisting cardiovascular risk factors like high blood pressure or atherosclerosis that could compound the stimulant’s effects.
For the vast majority of otherwise healthy people taking ADHD medications at prescribed doses, the absolute stroke risk remains very low. The situation changes if someone has uncontrolled hypertension, structural heart disease, or is combining stimulants with other drugs that raise blood pressure. Routine cardiovascular screening before starting stimulant therapy is standard practice for exactly this reason.
Anabolic Steroids
Anabolic-androgenic steroids (AAS), whether used for bodybuilding or performance enhancement, promote a pro-clotting state that can lead to stroke even in young, apparently fit individuals. A case report described an ischemic stroke in a 34-year-old recreational bodybuilder following a three-month steroid cycle, with the stroke attributed to a drug-related prothrombotic state combined with a previously undetected hole in the heart.18PubMed Central. Anabolic steroid use and ischaemic stroke in a young fitness enthusiast Steroids can thicken the blood by boosting red blood cell production, promote clot formation, damage the lining of blood vessels, and worsen cholesterol profiles, all of which feed into stroke risk. The post-cycle drugs people take to restart natural hormone production (like tamoxifen) carry their own clotting risks, compounding the problem.
Erythropoiesis-Stimulating Agents
Erythropoietin (EPO) and similar drugs that stimulate red blood cell production are used in patients with anemia from kidney disease or certain cancers. By raising the red blood cell count, they thicken the blood, which increases the chance of clots forming. The thrombotic risk is mainly reported when hemoglobin levels are pushed above the normal range, but even targeting levels in the upper-normal zone has been associated with more cardiovascular events in clinical trials.19PubMed Central. Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma The 2021 clinical review rated erythropoietin as having a high level of association with ischemic stroke.1Stroke / American Heart Association. Drugs Associated With Ischemic Stroke: A Review for Clinicians Current guidelines call for using the lowest effective dose and targeting hemoglobin levels well below normal to keep this risk manageable.
Calcineurin Inhibitors After Transplant
Cyclosporine and tacrolimus, the immunosuppressive drugs that keep transplanted organs from being rejected, have well-documented neurotoxic effects. Between 10% and 28% of patients receiving cyclosporine experience some form of neurological adverse event.20PubMed. Neurotoxicity of calcineurin inhibitors: impact and clinical management These drugs can injure blood vessels in the brain, particularly in the white matter at the back of the head, causing a condition called posterior reversible encephalopathy syndrome (PRES). In more severe cases, the vascular injury can progress to actual ischemia. Risk factors for serious complications include high drug blood levels, low magnesium, high blood pressure, and severe liver disease. Tacrolimus carries similar risks. Transplant teams monitor drug levels closely and adjust doses to walk the line between organ rejection and neurovascular toxicity.
Migraine Drugs
Ergotamine, one of the oldest migraine treatments, is a powerful vasoconstrictor that has been associated with ischemic events. A systematic review found that the pooled odds of serious ischemic events with ergotamine use were about 2.3 times higher than baseline.21PubMed. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies Triptans, the more modern migraine drugs, showed a much less consistent signal: one study found no increase, while another found a roughly 2.5-fold risk. The overall pooled estimate for triptans did not reach statistical significance. This distinction matters because triptans are prescribed far more frequently than ergotamines today. The lingering concern about triptans is mostly theoretical, based on the fact that they constrict cranial blood vessels, but the observational evidence has been reassuring for most patients. People with established coronary artery disease or prior stroke are generally advised to avoid both drug classes.
When Stopping a Drug Causes a Stroke
Paradoxically, abruptly stopping certain medications can also trigger a stroke. The best-studied example is aspirin. When someone who has been taking daily aspirin for cardiovascular protection suddenly stops, the body can experience a prothrombotic rebound. Experimental and clinical data suggest this rebound peaks within about four weeks of stopping aspirin, driven by the emergence of a new generation of platelets with unusually high clotting activity.22JAMA Neurology. Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke This does not mean you should never stop aspirin, but it does mean you should not stop it on your own without talking to a doctor, especially if you were prescribed it for stroke or heart attack prevention.
A related issue involves combining anticoagulants (blood thinners like warfarin or direct oral anticoagulants) with antiplatelet drugs. While these combinations are sometimes necessary, particularly in people with both atrial fibrillation and recent coronary stenting, they carry an increased long-term risk of intracerebral hemorrhage.23PubMed Central. Bleeding Risk With Combining Antiplatelets and Anticoagulants for Secondary Stroke Prevention: A Propensity Score-Matched Analysis The irony of stroke-prevention drugs increasing hemorrhagic stroke risk is not lost on clinicians; the trick is finding the duration and combination that minimizes total risk across both stroke types.
Drugs People Forget to Mention
When doctors take a medication history after a stroke, patients tend to report their prescription drugs but forget or downplay other exposures. Supplements, performance-enhancing drugs, recreational substances, and even cold medicine taken a few days before the event can all be relevant. The clinical review that catalogued 81 drugs associated with ischemic stroke also flagged some less obvious categories, including gonadotropin-releasing hormone agonists (used for prostate cancer and endometriosis) and certain HIV antiretroviral drugs like darunavir.1Stroke / American Heart Association. Drugs Associated With Ischemic Stroke: A Review for Clinicians Dose and treatment duration modify the risk for many of these drugs, so a short course may be perfectly safe while chronic use changes the equation.
For anyone with existing stroke risk factors, keeping an accurate, complete list of everything you take, including supplements and occasional over-the-counter products, gives your doctor the best chance of spotting a modifiable contributor. The intersection between a drug’s effect and your individual risk profile is what determines whether a given medication is safe, and that calculation only works if the doctor has the full picture.